Aprea Therapeutics plans Q4 2026 data update for APR-1051 trial
Aprea Therapeutics plans Q4 2026 data update for APR-1051 trial
Similar Posts
Aging Owners Will Free Up Millions of Homes Over the Next Decade
According to a new Realtor.com report, the generational housing handoff is underway, and over the next decade, Baby Boomers and members of the Silent Generation are expected to release 13.9 million homes. That’s 34% more than older households did in the last 10 years, according to new Realtor.com research. First-time buyers, however, shouldn’t expect a…
Corient Acquires $2.6B Cayman Islands Family Office
Corient is planting a flag in the Cayman Islands with the acquisition of a $2.6 billion multi-family office. FortCay Family Advisory is a wealth manager working with 14 ultra-high-net-worth families, offering wealth management, estate planning and other family office services. The firm was founded by Matt Houghton and Billy Harty, who said the move would…
Amfi announces initiatives to deepen mutual fund penetration | Finance News
2 min read Last Updated : Aug 21 2026 | 10:42 PM IST The Association of Mutual Funds in India (Amfi) announced a series of investor education initiatives on Friday, targeting women, first-time investors, smaller cities and underserved communities. It will conduct around 20 workshops across 10-12 cities to train 10,000 MF distributors on…
Home sales are the lowest they’ve been all year even though inventory is at a 7-year high
Home sales sank to the lowest level in 14 months, but the lack of demand pushed up the number of homes for sale up to nearly a 7-year high.
Trading 212 revenue up 70% to £345.8m in 2025
Trading 212 Group Limited grew revenue 70% to £345.8m in 2025 and more than doubled pre-tax profit to £127.7m, according to its accounts for the year to 31 December 2025, as reported by Finance Magnates and FX News Group. The group (company number 10014283) filed the accounts at Companies House on 2 October 2026. Revenue…
